EXPERIENCE WITH KETANSERIN, A SEROTONIN (S2) ANTAGONIST, IN LONGTERM TREATMENT OF ESSENTIAL-HYPERTENSION

被引：13

作者：

HEDNER, T ^{[1
]}

PERSSON, B ^{[1
]}

BERGLUND, G ^{[1
]}

机构：

[1] SAHLGRENSKA HOSP,DEPT MED 1,HYPERTENS UNIT,S-41345 GOTEBORG,SWEDEN

来源：

CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE | 1984年 / 6卷 / 03期

关键词：

D O I：

10.3109/10641968409044035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：743 / 751

页数：9

共 21 条

[1] 5-HYDROXYTRYPTAMINE IN BLOOD-PLATELETS OF CIRRHOTIC AND HYPERTENSIVE PATIENTS [J].

AHTEE, L ;

PENTIKAINEN, L ;

PENTIKAINEN, PJ ;

PAASONEN, MK .

EXPERIENTIA, 1974, 30 (11) :1328-1329

[2]

ANDREN L, 1983, 1ST EUR M HYP MIL

[3]

BERGLUND G, 1981, LANCET, V1, P744

[4]

BHAGAVA K, 1979, LIFE SCI, V25, P195

[5]

DECREE J, 1981, LANCET, V1, P1161

[6]

DECREE J, 1982, ANGIOLOGY, P137

[7]

DEMOULIN JC, 1981, LANCET, V1, P1186

[8]

FOUZARD JR, 1982, J CARDIOVASC PHARM, V4, P829

[9]

FRIES ED, 1960, PHYSIOL REV, V40, P27

[10] KETANSERIN, A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST - MONOTHERAPY IN ESSENTIAL-HYPERTENSION [J].

HEDNER, T ;

PERSSON, B ;

BERGLUND, G .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :121-125

← 1 2 3 →